Supporting Real-World, De-Identified Data Needs
​for Multiple Purposes

All stakeholders across the healthcare ecosystem seek innovations to enhance value and improve outcomes, CCT facilitates this through our Revalo™ Network.

Life science companies are seeking real-world, longitudinal, de-identified data to inform activities such as research & development, medical affairs, commercial strategies, and value analyses.

Value to Life Sciences and Med-Tech

· Access to real-world clinical data nationally and globally

· More thorough & efficient real-world product utilization, effectiveness & safety studies

· More thorough market, health economic and outcomes research

· Improved clinical trial feasibility analysis, planning & recruitment
​
· Value-based contract simulation 

CCT’s Global Healthcare Data Network™ (GHDN) provides rapid, cost-effective access to comprehensive real-world, de-identified data across multiple hospitals and health systems through a secure, federated query system that eliminates the need for source data to be exported to a centralized repository outside the firewall of the Provider’s organization.
The Global Healthcare Data Network provides secure and credentialed access, allowing authorized users among providers, life sciences & medical technology companies, and payers to explore and analyze data through rapid federated queries, with a complete audit trail.